The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma

H Chen, M Wang, T Weng, Y Wei, C Liu, L Yang… - … Oncology: Seminars and …, 2021 - Elsevier
Objective Upper urinary tract urothelial carcinoma (UTUC) is a relatively uncommon disease
with few reported molecular markers. This study evaluated Tim-3 and PD-1 expression in …

Outcomes of Intrarenal Bacillus Calmette-Guérin/Interferon-α2B for Biopsy-Proven Upper-Tract Carcinoma in Situ

EY Shapiro, MJ Lipsky, DY Cha… - Journal of …, 2012 - liebertpub.com
Abstract Background and Purpose: While nephroureterectomy (NU) remains the gold-
standard treatment for upper-tract carcinoma in situ (UT-CIS), it may be unnecessarily …

Salvage topical therapy for upper tract urothelial carcinoma

A Balasubramanian, MJ Metcalfe, G Wagenheim… - World journal of …, 2018 - Springer
Purpose Topical therapy (TT) for upper tract urothelial carcinoma (UTUC) has been explored
as a kidney sparing approach to treat carcinoma in situ (CIS) and as adjuvant for …

Intracavitary therapies for upper tract urothelial carcinoma

JJ Knoedler, JD Raman - Expert review of clinical pharmacology, 2018 - Taylor & Francis
Introduction: While radical nephroureterectomy remains the gold-standard for upper tract
urothelial carcinoma (UTUC), there is a growing push for organ-sparing therapy in low-risk …

The Utility of Intraluminal Therapies in Upper Tract Urothelial Carcinoma: A Narrative Review

J Tyrrell, W Chui, J Kealey, S Sengupta - Cancers, 2024 - mdpi.com
Simple Summary Tumours of the lining of the kidney and its drainage tube (the ureter) can
be treated by surgery carried out through fine telescopes. There is an increased risk of …

Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model

ME Pollard, AW Levinson, EY Shapiro, DY Cha… - Urology, 2013 - Elsevier
Objective To evaluate the degree of urothelial exposure using 3 upper tract delivery
techniques in an ex vivo porcine model, to determine the optimal modality to locally deliver …

Kidney-sparing surgery for upper tract urothelial cancer

I Lucca, T Klatte, M Rouprêt… - Current opinion in …, 2015 - journals.lww.com
KSS should be regarded as a valid alternative to RNU in case of technically resectable low-
risk upper tract urothelial cell carcinoma, even in case of a normal contralateral kidney …

Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy

T Inamoto, H Matsuyama, N Ibuki, K Komura… - The Journal of …, 2018 - Elsevier
Purpose In patients with urothelial carcinoma CIS (carcinoma in situ) generally has a poor
prognosis. However, to our knowledge the outcomes of pure/primary CIS and the behavior …

[HTML][HTML] Which is best method for instillation of topical therapy to the upper urinary tract? An in vivo porcine study to evaluate three delivery methods

Z Liu, J Ng, A Yuwono, Y Lu, YK Tan - International braz j urol, 2017 - SciELO Brasil
Purpose: To compare the staining intensity of the upper urinary tract (UUT) urothelium
among three UUT delivery methods in an in vivo porcine model. Materials and methods: A …

Diagnosis and management of upper tract urothelial carcinoma

I Lucca, JJ Leow, SF Shariat… - Hematology/Oncology …, 2015 - hemonc.theclinics.com
Urothelial cell carcinoma (UCC) is the fourth most common cancer worldwide, after prostate
(or breast), lung, and colorectal cancer. 1 Among UCC, upper tract urothelial carcinoma …